Liver disease is a common cause of premature death in the UK. Recently, The Lancet Commission on Liver Disease highlighted the financial impact liver disease places on the national healthcare system and businesses, and suggested strategies to reduce these burdens.
The negative impacts of liver disease on citizens under the age of 65 in the UK are escalating, particularly in those from low socioeconomic backgrounds. This can be reversed by targeting the three main causes of liver disease: alcohol misuse, obesity, and viral hepatitis. Previous attempts to change health outcomes through voluntary agreements with the food and drinks industries failed, emphasizing the need for tougher measures. Such measures are discussed in The Lancet Commission on Liver Disease for each of the three risk factors.
The Commission’s findings, Financial case for action on liver disease: Escalating costs of alcohol misuse, obesity and viral hepatitis can be downloaded here: http://www.liver-research.org.uk/liverresearch-assets/financialcaseforactiononliverdiseasepaper.pdf